Overview

Safety and Efficacy of NABOTA in Treatment of Essential Blepharospasm

Status:
Completed
Trial end date:
2018-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the Efficacy and Safety of NABOTA in treatment of essential blepharospasm
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Daewoong Pharmaceutical Co. LTD.
Treatments:
abobotulinumtoxinA
Botulinum Toxins
Botulinum Toxins, Type A
incobotulinumtoxinA
onabotulinumtoxinA